Physiolyte
Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, And Magnesium Chloride
B. Braun Medical Inc.
Human Prescription Drug
NDC 0264-2205Physiolyte also known as Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, And Magnesium Chloride is a human prescription drug labeled by 'B. Braun Medical Inc.'. National Drug Code (NDC) number for Physiolyte is 0264-2205. This drug is available in dosage form of Irrigant. The names of the active, medicinal ingredients in Physiolyte drug includes Magnesium Chloride - .03 g/100mL Potassium Chloride - .037 g/100mL Sodium Acetate - .37 g/100mL Sodium Chloride - .53 g/100mL Sodium Gluconate - .5 g/100mL . The currest status of Physiolyte drug is Active.
Drug Information:
| Drug NDC: | 0264-2205 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Physiolyte |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Prescription Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, And Magnesium Chloride |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | B. Braun Medical Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Irrigant |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | MAGNESIUM CHLORIDE - .03 g/100mL
POTASSIUM CHLORIDE - .037 g/100mL
SODIUM ACETATE - .37 g/100mL
SODIUM CHLORIDE - .53 g/100mL
SODIUM GLUCONATE - .5 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | IRRIGATION
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | NDA |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 08 Jun, 1984 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 25 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | NDA019024 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | B. Braun Medical Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 827351
827353
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 02F3473H9O
660YQ98I10
4550K0SC9B
451W47IQ8X
R6Q3791S76
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class: | Calculi Dissolution Agent [EPC]
Increased Large Intestinal Motility [PE]
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Magnesium Ion Exchange Activity [MoA]
Osmotic Activity [MoA]
Osmotic Laxative [EPC]
Potassium Compounds [CS]
Potassium Salt [EPC]
Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0264-2205-00 | 16 CONTAINER in 1 CASE (0264-2205-00) / 1000 mL in 1 CONTAINER | 08 Jun, 1984 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Product Elements:
Physiolyte sodium chloride, sodium gluconate, sodium acetate, potassium chloride, and magnesium chloride sodium chloride sodium cation chloride ion sodium gluconate sodium cation gluconic acid sodium acetate sodium cation acetate ion potassium chloride potassium cation chloride ion magnesium chloride magnesium cation chloride ion water acetic acid
Indications and Usage:
Indications and usage physiolyte⢠(a physiological irrigating solution) is indicated for all general irrigation, washing, and rinsing purposes which permit use of a sterile, nonpyrogenic electrolyte solution.
Warnings:
Warnings for irrigation only. not for injection. irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus, irrigation solutions must be regarded as systemic drugs. absorption of large amounts can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. the risk of dilutional states is inversely proportional to the electrolyte concentrations of the administered parenteral solutions. the risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations. do not warm above 150°f (66°c). after opening container, it's contents should be used promptly to minimize the possibility of bacterial growth or pyrogen formation. discard unused portion of irrigating solution since it contains no preservatives.
General Precautions:
General use aseptic technique when preparing and administering sterile irrigation solutions for irrigating body cavities, wounds and urethral catheters or for wetting dressings that come in contact with the body tissues. use only if solution is clear and container and seal are intact. do not use for irrigation that may result in absorption of large amounts into the blood. caution should be observed when the solution is used for continuous irrigation or allowed to "dwell" inside body cavities because of possible absorption into the blood stream and the production of circulatory overload. when used as a "pour" irrigation, no part of the contents should be allowed to contact the surface below the outer protected thread area of the plastic irrigation container. when used for irrigation via appropriate irrigation equipment, the administration set should be attached promptly. unused portions should be discarded and a fresh container of appropriate size used for the start up of each cycle or
Read more...repeat procedure. for repeated irrigations of urethral catheters, a separate container should be used for each patient.
Dosage and Administration:
Dosage and administration as required for irrigation. the dose is dependent upon the capacity or surface area of the structure to be irrigated and the nature of the procedure. when used as a vehicle for other drugs, the directions of the additive's manufacturer should be followed. some additives may be incompatible. consult with pharmacist. when introducing additives, use aseptic techniques. mix thoroughly. do not store. solutions should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permits.
Contraindications:
Contraindications physiolyte is not for injection by usual parenteral routes. an electrolyte solution should not be used for irrigation during electrosurgical procedures.
Adverse Reactions:
Adverse reactions possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes can be minimized when proper procedures are followed. displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. excessive volume or pressure during irrigation of closed cavities may cause undue distension or disruption of tissues. accidental contamination from careless technique may transmit infection. if an adverse reaction does occur, discontinue administration of the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Use in Pregnancy:
Pregnancy teratogenic effects pregnancy category c animal reproduction studies have not been conducted with physiolyte⢠(a physiological irrigating solution). it is also not known whether physiolyte⢠(a physiological irrigating solution) can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. physiolyte⢠(a physiological irrigating solution) should be given to a pregnant woman only if clearly needed.
Pediatric Use:
Pediatric use the safety and effectiveness of physiolyte in pediatric patients have not been established. its limited use in pediatric patients has been inadequate to fully define proper dosage and limitations for use.
Geriatric Use:
Geriatric use clinical studies of physiolyte⢠(a physiological irrigating solution) have not been performed to determine whether patients over 65 years of age respond differently from younger subjects. other reported clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. this drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Overdosage:
Overdosage in the event of overhydration or solute overload, reevaluate the patient's condition, and institute appropriate corrective treatment. intravascular volume overload may respond to hemodialysis. see warnings , precautions , and adverse reactions .
Description:
Description physiolyte is a sterile, nonpyrogenic solution of electrolytes in water for injection intended only for sterile irrigation, washing, and rinsing purposes. each 100 ml contains: sodium chloride usp 0.53 g; sodium gluconate usp 0.5 g sodium acetate trihydrate usp 0.37 g; potassium chloride usp 0.037 g; magnesium chloride hexahydrate usp 0.03 g water for injection usp qs glacial acetic acid usp has been added to adjust the ph ph: 6.8 (6.3â7.3) calculated osmolarity: the solution is isotonic (295 mosmol/liter) concentration of electrolytes (meq/liter): sodium 140 potassium 5; magnesium 3; chloride 98; acetate (ch 3 coo â ) 27 gluconate (hoch 2 (choh) 4 coo â ) 23 it contains no bacteriostat, antimicrobial agent or added buffer (except for ph adjustment) and is intended only for use as a single-dose or short procedure irrigation. when smaller volumes are required the unused portion should be discarded. physiolyte may be classified as a sterile irrigant, wash, rinse and pharmaceutical vehicle. the formulas of the active ingredients are: ingredients molecular formula molecular weight sodium chloride usp nacl 58.44 sodium acetate trihydrate usp ch 3 coonaâ¢3h 2 o 136.08 potassium chloride usp kcl 74.55 magnesium chloride hexahydrate usp mgcl 2 â¢6h 2 o 203.30 sodium gluconate usp 218.14 the plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. the copolymer contains no plasticizers and exhibits virtually no leachability. the plastic container is also virtually impermeable to vapor transmission and therefore, requires no overwrap to maintain the proper drug concentration. the safety of the plastic container has been confirmed by biological evaluation procedures. the material passes class vi testing as specified in the u.s. pharmacopeia for biological tests. the safety of the plastic has been confirmed by tests in animals according to usp biological standards for plastic containers. not made with natural rubber latex, pvc or dehp. chemical structure
Clinical Pharmacology:
Clinical pharmacology physiolyte exerts a mechanical cleansing action for sterile irrigation of body cavities, tissues or wounds, indwelling urethral catheters and surgical drainage tubes, and for washing, rinsing or soaking surgical dressings, instruments and laboratory specimens. it also serves as a vehicle for drugs used for irrigation or other pharmaceutical preparations. physiolyte provides an isotonic calcium-free balanced electrolyte irrigation with the same ionic composition as isolyte ® s (multi-electrolyte solution) a multiple electrolyte solution for iv replacement of acute extracellular fluid losses. physiological irrigation solutions are considered generally compatible with living tissues and organs. sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body
Read more...fluid. potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart. chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. magnesium, a principal cation of soft tissue, is primarily involved in enzyme activity associated with the metabolism of carbohydrates and protein. magnesium is also involved in neuromuscular and cardiac conduction and irritability. gluconate and acetate are organic ions which are hydrogen ion acceptors and contribute bicarbonate during their metabolism to carbon dioxide and water, and serve as alkalinizing agents. water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). water balance is maintained by various regulatory mechanisms. water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (na + ) plays a major role in maintaining physiologic equilibrium.
Carcinogenesis and Mutagenesis and Impairment of Fertility:
Carcinogenesis, mutagenesis, impairment of fertility studies with physiolyte⢠(a physiological irrigating solution) have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.
How Supplied:
How supplied physiolyte⢠(a physiological irrigating solution) is supplied sterile and nonpyrogenic in 1000 ml pic⢠(plastic irrigation containers) packaged 16 per case. ndc ref size physiolyte⢠(a physiological irrigating solution) 0264-2205-00 r5510-01 1000 ml exposure of pharmaceutical products to heat should be minimized. avoid excessive heat. protect from freezing. it is recommended that the product be stored at room temperature (25°c); however, brief exposure up to 40°c does not adversely affect the product. do not warm above 150°f (66°c).
Package Label Principal Display Panel:
Principal display panel - 1000 ml container label physiolyte⢠(a physiological irrigating solution) isotonic solution for irrigation ref r5510-01 ndc 0264-2205-00 1000 ml pic⢠container lot exp. each 100 ml contains: sodium chloride usp 0.53 g; sodium gluconate usp 0.5 g; sodium acetateâ¢3h 2 o usp 0.37 g; potassium chloride usp 0.037 g; magnesium chlorideâ¢6h 2 o usp 0.03g; water for injection usp qs glacial acetic acid usp to adjust ph ph: 6.8 (6.3-7.3) calc. osmolarity: 295 mosmol/liter electrolytes (meq/liter): na + 140 k + 5 mg + + 3 ci â 98 acetate 27 gluconate 23 sterile, nonpyrogenic. single unit container. not for injection. use only if solution is clear and container and seal are intact. warning: do not warm above 150°f (66°c). recommended storage: room temperature (25°c). avoid excessive heat. protect from freezing. see package insert. rx only not made with natural rubber latex, pvc or dehp. b. braun medical inc. bethlehem, pa 18018-3524 usa 1-800-227-2862 physiolyte and pic are trademarks of b. braun medical inc. y37-002-508 ld-519-1 1000 ml container label r5510-01